BNGO vs. OPXS, ODYS, OPTX, AATC, CLIR, DAIO, MSAI, PRPO, STAI, and ASTC
Should you be buying Bionano Genomics stock or one of its competitors? The main competitors of Bionano Genomics include Optex Systems (OPXS), Odysight.ai (ODYS), Syntec Optics (OPTX), Autoscope Technologies (AATC), ClearSign Technologies (CLIR), Data I/O (DAIO), MultiSensor AI (MSAI), Precipio (PRPO), ScanTech AI Systems (STAI), and Astrotech (ASTC). These companies are all part of the "measuring and control equipment" industry.
Bionano Genomics vs. Its Competitors
Optex Systems (NASDAQ:OPXS) and Bionano Genomics (NASDAQ:BNGO) are both small-cap measuring and control equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, institutional ownership and media sentiment.
Optex Systems has higher revenue and earnings than Bionano Genomics. Bionano Genomics is trading at a lower price-to-earnings ratio than Optex Systems, indicating that it is currently the more affordable of the two stocks.
19.1% of Optex Systems shares are held by institutional investors. Comparatively, 11.4% of Bionano Genomics shares are held by institutional investors. 30.3% of Optex Systems shares are held by company insiders. Comparatively, 0.9% of Bionano Genomics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Optex Systems has a net margin of 13.01% compared to Bionano Genomics' net margin of -271.02%. Optex Systems' return on equity of 24.67% beat Bionano Genomics' return on equity.
In the previous week, Optex Systems had 1 more articles in the media than Bionano Genomics. MarketBeat recorded 2 mentions for Optex Systems and 1 mentions for Bionano Genomics. Optex Systems' average media sentiment score of 0.40 beat Bionano Genomics' score of 0.00 indicating that Optex Systems is being referred to more favorably in the media.
Bionano Genomics has a consensus target price of $7.50, indicating a potential upside of 87.97%. Given Bionano Genomics' stronger consensus rating and higher possible upside, analysts clearly believe Bionano Genomics is more favorable than Optex Systems.
Optex Systems has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. Comparatively, Bionano Genomics has a beta of 2.25, meaning that its stock price is 125% more volatile than the S&P 500.
Summary
Optex Systems beats Bionano Genomics on 12 of the 16 factors compared between the two stocks.
Get Bionano Genomics News Delivered to You Automatically
Sign up to receive the latest news and ratings for BNGO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding BNGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Bionano Genomics Competitors List
Related Companies and Tools
This page (NASDAQ:BNGO) was last updated on 9/6/2025 by MarketBeat.com Staff
Free BNGO Stock Alerts